The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy.

TitleA novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy.
Publication TypeJournal Article
Year of Publication2012
AuthorsAsh, D. B., Papadimitriou D., Hays A. P., Dimauro S., & Hirano M.
JournalArch Neurol
Volume69
Issue9
Pagination1190-2
Date Published2012 Sep
ISSN1538-3687
KeywordsAged, Humans, Lipase, Lipid Metabolism, Inborn Errors, Male, Muscle, Skeletal, Muscular Diseases, Mutation, Pedigree
Abstract

BACKGROUND: Mutations in PNPLA2, a gene encoding adipose triglyceride lipase, lead to neutral lipid storage disease with myopathy.OBJECTIVE: To report the clinical and molecular features of a case of neutral lipid storage disease with myopathy resulting from a novel mutation in PNPLA2.DESIGN: Case report.SETTING: University hospital.PATIENT: A 65-year-old man with progressive muscle weakness and high serum creatine kinase levels.INTERVENTION: Direct sequencing of the PNPLA2 gene.RESULTS: Identification of a novel homozygous mutation in the patient's PNPLA2 gene confirmed the suspected diagnosis of neutral lipid storage disease with myopathy.CONCLUSION: Screening of the PNPLA2 gene should be considered for patients presenting with high levels of creatine kinase, progressive muscle weakness, and systemic lipid accumulation. The presence of Jordans anomaly can be a strong diagnostic clue.

DOI10.1001/archneurol.2011.2600
Alternate JournalArch. Neurol.
PubMed ID22964912
Grant ListP01HD032062 / HD / NICHD NIH HHS / United States
R01 HD056103 / HD / NICHD NIH HHS / United States
R01HD057543 / HD / NICHD NIH HHS / United States
RC1NS070232 / NS / NINDS NIH HHS / United States

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.